
Quanterix (QTRX) Stock Forecast & Price Target
Quanterix (QTRX) Analyst Ratings
Bulls say
Quanterix is viewed favorably because 3Q revenue of $35.0M beat forecasts and consensus, with Simoa and Spatial both ahead of expectations, consumables up 10% year over year, and adjusted EBITDA loss of ($4.3M) far better than expected, showing improving execution despite weak end markets. The new management team has reorganized commercial efforts into specialized Simoa, Spatial, and Accelerator groups, and early evidence of traction appears in stronger bookings, higher instrument placements, and Accelerator bookings near 2x book-to-bill, while cost discipline has supported cash preservation and a path to cash flow breakeven in '27. The long-term bull case is reinforced by LucentAD and broader diagnostics momentum, including doubling clinical test volumes sequentially, new reference lab partnerships, Florida Medicaid coverage at about $484 per test, and a still-expanding menu of assays and spatial panels that could diversify growth beyond academic demand.
Bears say
Quanterix is facing a negative fundamental setup after a weak 2Q and a ~40% selloff, with revenue of $32.9M coming in 10% below forecast and 12% below consensus as both core Simoa and Akoya missed expectations. Management’s 15% midpoint cut to FY26 revenue guidance to $142M-$148M, alongside lower gross margin guidance of 48%-50% and a delayed cash flow break-even outlook to 2027, signals that challenged A&G and Pharma demand is being compounded by commercial execution issues. Although the new CEO is making organizational changes and expects cash-efficient improvement, the company still anticipates no end-market recovery and continued Spatial weakness through 2026, keeping fundamentals under pressure despite an expected ~$80M cash balance and no debt exiting FY26.
This aggregate rating is based on analysts' research of Quanterix and is not a guaranteed prediction by Public.com or investment advice.
Quanterix (QTRX) Analyst Forecast & Price Prediction
Start investing in Quanterix (QTRX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Quanterix (QTRX) Forecast
Quanterix (QTRX) Analyst Forecast & Price Prediction
Start investing in Quanterix (QTRX)
Order type
Buy in
Order amount
Est. shares
0 shares